血管内成像指导与冠状动脉造影指导的经皮冠状动脉介入治疗:系统综述与荟萃分析
该系统综述与荟萃分析纳入20项随机对照试验(n=11 698),比较血管内成像(血管内超声或光学相干断层扫描)指导与冠状动脉造影指导的经皮冠状动脉介入治疗。血管内成像指导与心源性死亡(率比0.53,95%CI 0.39-0.72)、心肌梗死(0.81,0.68-0.97)、支架血栓(0.44,0.27-0.72)、靶血管血运重建(0.74,0.61-0.89)和靶病变血运重建(0.71,0.59-0.86)风险降低相关,但全因死亡无显著差异(0.81,0.64-1.02)。基于SYNTAX风险分类,从低危到高危,血管内成像每1000人可能减少23至64例心源性死亡、15至19例心肌梗死、9至13例支架血栓、28至38例靶血管血运重建和35至48例靶病变血运重建。
要点
- 在20项随机对照试验(n=11 698)中,血管内成像指导的经皮冠状动脉介入治疗与心源性死亡风险降低相关(率比0.53,95%CI 0.39-0.72)。
- 血管内成像指导还与心肌梗死(率比0.81,95%CI 0.68-0.97)、支架血栓(率比0.44,95%CI 0.27-0.72)、靶血管血运重建(率比0.74,95%CI 0.61-0.89)和靶病变血运重建(率比0.71,95%CI 0.59-0.86)风险降低相关。
- 全因死亡风险无显著差异(率比0.81,95%CI 0.64-1.02)。
- 基于SYNTAX风险分类,从低危到高危,血管内成像每1000人可能减少23至64例心源性死亡、15至19例心肌梗死、9至13例支架血栓、28至38例靶血管血运重建和35至48例靶病变血运重建。
- 绝对效应与基线风险成比例,由冠状动脉疾病的严重程度和复杂性驱动。
适用人群与场景
- 成人冠心病患者,比较血管内成像(血管内超声或光学相干断层扫描)指导与冠状动脉造影指导的经皮冠状动脉介入治疗。
研究设计与关键结果
- 系统综述与荟萃分析纳入20项随机对照试验(n=11 698),比较血管内成像指导与冠状动脉造影指导的经皮冠状动脉介入治疗。
- 血管内成像指导与心源性死亡风险降低相关(率比0.53,95%CI 0.39-0.72)。
- 血管内成像指导与心肌梗死风险降低相关(率比0.81,95%CI 0.68-0.97)。
- 血管内成像指导与支架血栓风险降低相关(率比0.44,95%CI 0.27-0.72)。
- 血管内成像指导与靶血管血运重建风险降低相关(率比0.74,95%CI 0.61-0.89)。
- 血管内成像指导与靶病变血运重建风险降低相关(率比0.71,95%CI 0.59-0.86)。
- 全因死亡风险无显著差异(率比0.81,95%CI 0.64-1.02)。
- 基于SYNTAX风险分类,从低危到高危,血管内成像每1000人可能减少23至64例心源性死亡、15至19例心肌梗死、9至13例支架血栓、28至38例靶血管血运重建和35至48例靶病变血运重建。
证据类型、等级与局限
- 证据类型:系统综述与荟萃分析,纳入20项随机对照试验。
- 使用GRADE评估证据确定性;高确定性证据显示血管内成像指导与心源性死亡等结局的绝对效应。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与冠状动脉造影指导的经皮冠状动脉介入治疗相比,血管内成像指导的经皮冠状动脉介入治疗与心源性死亡和心血管结局显著降低相关。
- 作者认为,血管内成像指导的经皮冠状动脉介入治疗的估计绝对效应与基线风险成比例,由冠状动脉疾病的严重程度和复杂性驱动。
指南或共识出处
- PROSPERO CRD42023433568。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk.
DESIGN: Systematic review and meta-analysis.
DATA SOURCES: PubMed/Medline, Embase, and Cochrane Library databases up to 31 August 2023.
STUDY SELECTION: Randomized controlled trials comparing intravascular imaging (intravascular ultrasonography or optical coherence tomography) guided versus coronary angiography guided percutaneous coronary intervention in adults with coronary artery disease.
MAIN OUTCOME MEASURES: Random effect meta-analysis and GRADE (grading of recommendations, assessment, development, and evaluation) were used to assess certainty of evidence. Data included rate ratios and absolute risks per 1000 people for cardiac death, myocardial infarction, stent thrombosis, target vessel revascularization, and target lesion revascularization. Absolute risk differences were estimated using SYNTAX risk categories for baseline risks at five years, assuming constant rate ratios across different cardiovascular risk thresholds.
RESULTS: In 20 randomized controlled trials (n=11 698), intravascular imaging guided percutaneous coronary intervention was associated with a reduced risk of cardiac death (rate ratio 0.53, 95% confidence interval 0.39 to 0.72), myocardial infarction (0.81, 0.68 to 0.97), stent thrombosis (0.44, 0.27 to 0.72), target vessel revascularization (0.74, 0.61 to 0.89), and target lesion revascularization (0.71, 0.59 to 0.86) but not all cause death (0.81, 0.64 to 1.02). Using SYNTAX risk categories, high certainty evidence showed that from low risk to high risk, intravascular imaging was likely associated with 23 to 64 fewer cardiac deaths, 15 to 19 fewer myocardial infarctions, 9 to 13 fewer stent thrombosis events, 28 to 38 fewer target vessel revascularization events, and 35 to 48 fewer target lesion revascularization events per 1000 people.
CONCLUSIONS: Compared with coronary angiography guided percutaneous coronary intervention, intravascular imaging guided percutaneous coronary intervention was associated with significantly reduced cardiac death and cardiovascular outcomes in patients with coronary artery disease. The estimated absolute effects of intravascular imaging guided percutaneous coronary intervention showed a proportional relation with baseline risk, driven by the severity and complexity of coronary artery disease.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42023433568.
参考来源
- Khan SU, Agarwal S, Arshad HB, et al. Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2023. PMID: 37973170. doi:10.1136/bmj-2023-077848
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。